3.2
Impact Factor
Volume 16 (13); 2025
Research Papers
Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma
Ryan J. Sullivan, Katy K. Tsai, Anna C. Pavlick, Elizabeth I. Buchbinder, Sanjiv S. Agarwala, Antoni Ribas, Johan Jansson, Guillermo Rossiter, Anthony J. Olszanski
J. Cancer 2025; 16(13): 3797-3809. doi:10.7150/jca.117878
Full text
PDF
Pseudouridylation-Related Genes Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma Patients
Chenlu Lan, Donghua Gao, Yongguang Wei, Huasheng Huang, Xianwei Lv, Xin Zhou, Wei Qin, Xiwen Liao, Guangzhi Zhu, Tao Peng
J. Cancer 2025; 16(13): 3823-3841. doi:10.7150/jca.117247
Full text
PDF
Lipid-Coated Mesoporous Silica Particles for pH-Sensitive Tumor-Targeted Paclitaxel: Development, Characterization
Yingyue Deng, Tao Zhang, Jiaru Zhou, Zhihao Su, Yingsong Cao, Junxi Luo, Leming Zhao, Junjie Hua, Guoqiang Wang, Min Xiao, Junfeng Ban, Yan Zhang, Hongcai Liang
J. Cancer 2025; 16(13): 3842-3850. doi:10.7150/jca.117433
Full text
PDF
Robust machine-learning based prognostic index using fatty acid metabolism genes predicts prognosis and therapy responses in glioblastoma
Erjie Zhao, Zihan Wang, Liya Tang, Longxiu Zhang, Liuguijie He, Mengdie Li, Xin Ge, Zhumei Shi, Xu Qian, Risheng Cao
J. Cancer 2025; 16(13): 3859-3873. doi:10.7150/jca.117209
Full text
PDF
Prognostic significance and potential association between ALDOA and ENO1 in gastric cancer
Xuchao Wang, Yibin Lu, Zhengwu Cheng, Yizhou Yao, Xinyu Shao
J. Cancer 2025; 16(13): 3874-3883. doi:10.7150/jca.114369
Full text
PDF
CD40LG Downregulation in Lung Adenocarcinoma: A Prognostic Biomarker Linked to Immune Cell Infiltration and Survival Outcomes
Peng Tang, Ruihao Zhang, Yuqi Zhang, Yuan Ao, Yanan Wang, Guannan Wang, Wenjun Wang, Junmei Xu, Fang Hu, Guangsheng Zhu
J. Cancer 2025; 16(13): 3884-3896. doi:10.7150/jca.115525
Full text
PDF
Reviews
Insight into the Role of the BCL6B Gene in Biological Functions and Disease Progression
Yuqing Pan, Ya Li
J. Cancer 2025; 16(13): 3810-3822. doi:10.7150/jca.116659
Full text
PDF
HKDC1 in Cancer: Mechanisms, Clinical Applications, and Future
Xia Luo, Mingjing Peng, Zhan Wang, Nayiyuan Wu, Ying Wang
J. Cancer 2025; 16(13): 3851-3858. doi:10.7150/jca.116277
Full text
PDF
Letter
Correspondence on “Robotic radical hysterectomy for cervical cancer: current trends and controversies”
Agnieszka Rychlik, Maria Bedyńska, Denis Querleu
J. Cancer 2025; 16(13): 3897-3898. doi:10.7150/jca.114989
Full text
PDF